ask="N/A"
ask_size="N/A"
average_daily_volume="602695"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="-0.92"
change_from_200_day_moving_average="7.26"
change_from_50_day_moving_average="-1.39"
change_from_52_week_high="-20.55"
change_From_52_week_low="27.33"
change_in_percent="-1.23%"
close="73.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="75.94"
high_52_weeks="94.40"
last_trade_date="1/10/2017"
last_trade_price="73.85"
last_trade_size="26153"
last_trade_time="4:00pm"
low="72.36"
low_52_weeks="46.52"
market_capitalization="3.02B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="75.23"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="+10.91%"
percent_change_from_50_day_moving_average="-1.85%"
percent_change_from_52_week_high="-21.77%"
percent_change_from_52_week_low="+58.75%"
previous_close="74.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.57"
price_per_sales="23867.40"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="364643"
weeks_range_52="46.52 - 94.40"
